SCHEMBL6132770

SCHEMBL6132770

CC(=O)N1CC(=O)NC(Cc2cc3ccccc3[nH]2)C1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 2/20 0.50
MTNR1A P48039 1/20 0.43
MTNR1B P49286 1/20 0.43
ITGB3 P05106 1/20 0.41
ITGAV P06756 1/20 0.41
TSHR P16473 1/20 0.39
HRH4 Q9H3N8 1/20 0.38
CHRNA7 P36544 1/20 0.38
HCRTR1 O43613 1/20 0.37
HCRTR2 O43614 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
AKR1C3 P42330 1/20 0.37
HRH3 Q9Y5N1 3/20 0.37
LOXL2 Q9Y4K0 1/20 0.37
PYGL P06737 1/20 0.36
PYGM P11217 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
DPP4 P27487 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6132870 0.72 HDAC8 (0.64) HDAC8MTNR1AMTNR1BHRH4CHRNA7
SCHEMBL5557284 0.71 HDAC6 (0.45) HDAC8LMNAHDAC6
SCHEMBL5557293 0.71 HDAC6 (0.45) HDAC8LMNAHDAC6
SCHEMBL6132863 0.70 OPRK1 (0.44) MTNR1AMTNR1BMAPTHDAC6
SCHEMBL8726569 0.70 HDAC8 (0.46) HDAC8HRH4CHRNA7MAPTHRH3
SCHEMBL8722155 0.68 HDAC8 (0.47) HDAC8HRH4CHRNA7MAPTHRH3
SCHEMBL6133229 0.67 OPRK1 (0.51) LMNA
SCHEMBL8726559 0.67 NPSR1 (0.48) HDAC8TSHRHCRTR1HCRTR2LMNA
SCHEMBL1011574 0.67 HDAC8 (0.65) HDAC8MTNR1AMTNR1BHRH3LOXL2
SCHEMBL6132883 0.67 MEN1 (0.56) TSHRHRH4MAPTNPSR1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6924278-B2 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-08-02 US disclosed
US-20050027121-A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-02-03 US disclosed
US-20030114668-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-19 US disclosed
EP-0993457-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-19 EP disclosed
WO-1998057954-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050027121-A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists TAC3, TACR1, SSTR5 HDAC8 2146/4885MTNR1A 587/4885MTNR1B 369/4885
US-20030114668-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS TACR1, NPSR1, SSTR2 HDAC8 2041/4885MTNR1A 338/4885MTNR1B 311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.